Content
Frontiers of Medicine >> 2022, Volume 16, Issue 3 doi: 10.1007/s11684-021-0840-y
Proteomics study of Mycoplasma pneumoniae pneumonia reveals the Fc fragment of the IgG-binding protein as a serum biomarker and implicates potential therapeutic targets
Abstract
Keywords
severe Mycoplasma pneumoniae pneumonia ; children ; proteomics ; Fc fragment of the IgG-binding protein ; mechanistic target of rapamycin kinase inhibitor
Content